Wart Remover

Description

The product is identified by the SPL code 34089-3. No additional specific description details are available.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. Common warts are characterized by a rough, "cauliflower-like" surface, facilitating their identification. Plantar warts are specifically located on the soles of the feet, presenting tenderness upon touch and disrupting the natural skin line pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed and dried thoroughly prior to application. A sufficient amount of the medication should be applied using a cotton swab to ensure complete coverage of each wart. It is important to allow the application to dry completely.

The recommended dosing frequency is twice daily, with 2 to 3 applications per use. This regimen should be followed daily for a duration of 5 to 7 days to achieve optimal results.

Contraindications

Use is contraindicated on damaged skin, including areas with cuts, abrasions, eczema, or sunburn, due to the potential for exacerbating skin irritation and delaying healing. Additionally, the product should not be used in patients with diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects and complications.

Warnings and Precautions

Contact with the eyes, mouth, and open wounds must be strictly avoided. In the event of accidental exposure, it is imperative to rinse the affected area immediately. Should irritation persist, prompt medical attention is required. Additionally, this product should be kept out of reach of children and pets to prevent accidental ingestion or exposure.

General precautions must be observed to ensure safe use. In particular, if the product is ingested, immediate medical assistance should be sought, or the Poison Control Center should be contacted at 1-800-222-1222. It is essential that children use this product only under adult supervision. The product should not be applied to damaged skin, including areas with cuts, abrasions, eczema, or sunburn. Special caution is advised for individuals with diabetes or poor blood circulation, as they may be at increased risk for complications.

Healthcare professionals should instruct patients to discontinue use and contact their doctor if any irritation or allergic reaction occurs. In cases of ingestion, immediate medical help is necessary, and the Poison Control Center should be contacted without delay.

Side Effects

Patients should be advised to avoid contact with the eyes, mouth, and open wounds. In the event of accidental exposure, it is recommended to rinse the affected area immediately. Should irritation persist, medical attention should be sought without delay.

Additionally, the product should be kept out of reach of children and pets to prevent accidental ingestion or exposure.

Patients are instructed to discontinue use if irritation or an allergic reaction occurs.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover (salicylic acid 17% wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this medication only under adult supervision to ensure safety and proper administration. It is important to keep the product out of reach of children and pets to prevent accidental ingestion or misuse.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult their healthcare provider before using this medication. It is essential to evaluate the potential risks and benefits associated with the use of this drug during pregnancy and lactation. Healthcare professionals are advised to consider the individual circumstances of each patient when making recommendations.

Lactation

Lactating mothers are advised to consult their healthcare provider if they are pregnant or breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, healthcare professionals should consider the potential risks and benefits when prescribing this medication to lactating mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

For further management, consultation with a poison control center or a medical toxicologist is recommended to obtain guidance tailored to the specific circumstances of the overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children and pets to prevent accidental ingestion. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

It is important to inform patients that children should use the medication only under adult supervision to ensure safety. Providers should also caution patients against applying the medication on damaged skin, including cuts, abrasions, eczema, or sunburn, as this may lead to adverse effects.

Patients with diabetes or poor blood circulation should be made aware of the potential risks associated with the use of this medication. They should be advised to monitor for any signs of irritation or allergic reactions, and to discontinue use and seek medical advice if such reactions occur.

Additionally, patients should be informed that skin discoloration may occur during or after the use of the medication. Pregnant or breastfeeding patients should be counseled to discuss their condition with their healthcare provider before using the medication to ensure it is safe for them.

Storage and Handling

The product is supplied in a container that requires careful handling to maintain its integrity. It is essential to avoid prolonged exposure to air, as this can lead to volatilization and crystallization of the liquid. To ensure optimal storage conditions, the cap should be tightened securely after each use to prevent air ingress.

For best results, the product should be stored in a cool, dry place, away from direct sunlight and extreme temperatures. Adhering to these storage guidelines will help preserve the quality and efficacy of the product.

Additional Clinical Information

The product is administered topically, with a recommended application frequency of twice daily, allowing for 2-3 applications per use over a duration of 5-7 days. Clinicians should counsel patients to consult their doctor if they are pregnant, breastfeeding, or have diabetes. Additionally, it is advised that children use the product under adult supervision. No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)